- Collagenous colitis
- Crohn's disease
- Lymphocytic colitis
- Microscopic colitis
- Pouchitis
- Ulcerative colitis (UC)
- Colonoscopy
- J-pouch surgery
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Publications
Alexandra Weiss MD, Edward L Barnes MD MPH, Meenakshi Bewtra MD PhD MPH A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's disease , American Journal of Gastroenterology: 2024
James D Lewis, Lauren E Parlett, Michele L Jonsson Funk, Colleen Brensinger, Virginia Pate, Qufei Wu, Ghadeer K Dawwas, Alexandra Weiss, Brad D Constant, Maureen McCauley, Kevin Haynes, Jeff Yufeng Yang, Douglas E Schaubel, Andres Hurtado-Lorenzo, Michael David Kappelman Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States , Gastroenterology : 2023
Thanawala S, Weiss AH, Weber A, Tang H, Buchner A. The role of liver transplant in the development of colorectal dysplasia in patients with PSC-IBD. (Poster Presentation) , DDW: 2023
Weiss AH, Thanawala S, Tang H, Weber A, Buchner A. Severity of inflammation as a risk factor for the development of colorectal dysplasia in PSC-IBD. (Poster Presentation) , DDW: 2023
Khan N, Pernes T, Weiss A, Trivedi C, Patel M, Medvedeva E, Xie D, Yang YX Efficacy of Vedolizumab in a nationwide cohort of elderly inflammatory bowel disease patients , Inflammatory Bowel Diseases : 2022
Weiss, A.H. and Buchner, A.M Editorial: colorectal cancer in elderly-onset inflammatory bowel disease—what is the risk? , Aliment Pharmacol Ther, 56(9): 2022,1421-1422
Mahmud N, Weiss A, Trivedi C, Yang YXm Lewis J, Khan N Risk of venous thromboembolism among patients with inflammatory bowel disease who contract severe acute respiratory syndrome Coronavirus 2 , Gastroenterology, 161: 2021
Weiss AH, Trivedi C, Pernes T, Patel M, Khan N. Efficacy of vedolizumab in a nationwide cohort of elderly inflammatory bowel disease patients. (Poster Presentation) , DDW : 2021
Weiss AH, Bhattacharya A, Ellison S, Osterman MT, Lichtenstein G Lower Adalimumab trough levels are associated with higher risk of infectious complications in patients with IBD , DDW : 2021
Weiss AH, Trivedi C, Pernes T, Patel M, Khan N Incidence of infections and malignancy among elderly IBD patients exposed to vedolizumab, prednisone and mesalamine (Poster Presentation) , DDW : 2021